ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

How Bacopa Can Help Improve Your Cognitive Function

Black Tea Is Great for Your Gut

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Mint: Learn More About This Refreshing and Invigorating Herb

Give Your Health a Much-Needed Boost With Geranium

 
Print Page
Email Article

Hemispherx Announces Study that Advances Chronic Fatigue Syndrome (CFS) Programs in Europe

  [ 28 votes ]   [ Discuss This Article ]
By Hemispherx Biopharma, Inc. • www.ProHealth.com • February 11, 2000


PHILADELPHIA, Feb. 11 /PRNewswire/ -- Hemispherx Biopharma, Inc. (Amex: HEB; HEBws) announced that results published today in a leading medical journal show a new one-step diagnostic test for Chronic Fatigue Syndrome (CFS) in European programs has accurately identified this debilitating condition in patients, which may thereby accelerate the overall process of effective therapeutic intervention.

The breakthrough results, published in the peer-reviewed medical journal, "American Journal of Medicine," are part of a study by leading researchers in France and Belgium who are members of the Scientific Advisory Committee for Hemispherx Europe. The researchers evaluated more than 100 patients with different disorders under "blinded conditions" and found that a new biological marker, which was targeted to CFS, was not evident in patients with other fatiguing conditions such as fibromyalgia or depression.

CFS is a chronic debilitating condition characterized by disabling fatigue, fever, myalgia and neurocognitive disturbances. Because a new diagnostic test can identify CFS in patients, therapeutic intervention can take place much more quickly. In fact, certain patients in this study who were diagnosed with CFS using this new test received Ampligen(R), a new product for which Hemispherx Europe has pending marketing applications in 15 European countries.

In related developments, Hemispherx said that the European Parliament recently passed new laws which will accelerate the availability of specific treatments for CFS, and EU member nations, including Italy and Belgium, are actively taking new official regulatory steps to facilitate reimbursement of new medications, which may potentially interrupt the natural history and devastating societal impact of untreated CFS.

Hemispherx Biopharma, which is based in Philadelphia, is a pharmaceutical company engaged in the manufacture and global clinical development of new drug entities in the nucleic acid (NA) class for chronic viral diseases and disorders of the immune system including CFS, HIV and hepatitis. Its flagship products are Ampligen(R), which is being developed for CFS and drug-resistant HIV, and polyadenur, which is being developed for hepatitis B and C.

Information contained in this news release other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed in this release and in the Company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements.

Contact: William A. Carter, M.D., CEO & Chairman of Hemispherx Biopharma, Inc., 215-988-0080; or Mark Kollar of Broadgate Consultants, 212-232-2222, fax, 212-232-3232; or Dianne Will, Investor Relations, 214-954-9300, fax, 214-954-9333



Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength FibroSleep™ Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Undenatured Type II Collagen - Chicken Soup for Your Joints Undenatured Type II Collagen - Chicken Soup for Your Joints
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
Coconut Oil - Healthy Gifts from the 'Tree of Life' Coconut Oil - Healthy Gifts from the 'Tree of Life'
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine
Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map